Mouse study: senolytic 753b slowed disc aging in males, not females
In aging mice, long-term systemic 753b reduced signs of intervertebral disc degeneration in 22-month-old males but not females, per the description. [1]
Automatic summary · not editorially reviewed
The key findings
Five aging male and female mice received 753b or vehicle intraperitoneally between 16 and 22 months of age. [1]
In 22-month-old males, 753b reduced aggrecan breakdown, aggrecan loss, disc degeneration features and serum IL-6 and TNFα. [1]
Disc senescence marker expression rose with age in both sexes and was not reduced by 753b. [1]
The source at a glance
- Study type / format
- Preclinical mouse study (abstract in a video description)
- Population / context
- Aging male and female mice aged 16 to 22 months.
- Summary based on
- Creator description
- Original publication
- July 27, 2026
Mice given 753b or vehicle from 16 to 22 months
The description reports a mouse study of the senolytic PROTAC 753b, which it says removes senescent cells by targeting BCL-2/BCL-xL proteins. Five aging male and female mice were injected intraperitoneally with 753b or vehicle between 16 and 22 months of age. The aim was to test whether systemic treatment reduces age-related intervertebral disc degeneration.
Supporting source [1]
Less disc degeneration in treated males; markers unchanged
Among vehicle controls, 22-month-old males showed significantly greater disc degeneration than age-matched females. In 22-month-old males, 753b significantly reduced matrix metalloproteinase-mediated aggrecan breakdown, aggrecan loss, age-related disc degeneration features and serum IL-6 and TNFα levels. Yet disc expression of senescence markers IL-6, IL-8, TNFα and p16INK4a rose with age in both sexes and was not reduced by 753b.
Supporting source [1]
Sex difference in mice; abstract-only scope
The authors conclude that 753b reduced disc degeneration in male but not female mice, suggesting sex-based differences in how senescence contributes to disc degeneration. They propose this may affect whether females could benefit from anti-senescence therapies for disc degeneration. These are mouse findings; the description gives only the abstract, and the full text was not reviewed.
Supporting source [1]
How to interpret this
This is a video description containing only the abstract; the video and transcript were not reviewed. Findings are in mice, not humans, and the description does not report full methods or all results.
Based on the creator’s description; the full video and transcript were not analyzed.
Source & supporting passages
Aging Journal · youtube.com · July 27, 2026